Wrap-up Bendamustin 2015 Levact (R) proved itself as a Chemotherapy Partner in CLL and other indolent Lymphomas

Ortner Petra; Knauf Wolfgang

首页> 外文期刊>Oncology research and treatment. >Wrap-up Bendamustin 2015 Levact (R) proved itself as a Chemotherapy Partner in CLL and other indolent Lymphomas

【24h】

Wrap-up Bendamustin 2015 Levact (R) proved itself as a Chemotherapy Partner in CLL and other indolent Lymphomas

机译：总结Bendamustin 2015 Levact（R）证明自己是CLL和其他惰性淋巴瘤的化疗合作伙伴

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Oncology research and treatment.》 |2015年第12期|共2页
作者
Ortner Petra; Knauf Wolfgang;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. Wrap-up Bendamustin 2015 Levact (R) proved itself as a Chemotherapy Partner in CLL and other indolent Lymphomas [J] . Ortner Petra, Knauf Wolfgang Oncology research and treatment. . 2015,第12期

机译：总结Bendamustin 2015 Levact（R）证明自己是CLL和其他惰性淋巴瘤的化疗合作伙伴
2. Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT. [J] . Dreger P, Glass B, Seyfarth B, Bone marrow transplantation . 2000,第12期

机译：自体SCT失败后低强度异体干细胞移植作为惰性淋巴瘤或CLL患者的救治方法。
3. Combined rituximab, bendamustine, and dexamethasone chemotherapy for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma: a multicenter phase II study [J] . Matsumoto Yosuke, Kobayashi Tsutomu, Shimura Yuji, International journal of hematology . 2019,第1期

机译：用于复发或难治性惰性B细胞非霍奇金淋巴瘤和地幔细胞淋巴瘤的rituximab，Bendamustine和地塞米松化学疗法：多中心二期研究
4. Multiple cystic lung lesions and autoimmune thrombocytopaenia developing after chemotherapy for pulmonary indolent B-cell lymphoma with plasmacytic differentiation [O] . Hiroaki Tanaka, Chihiro Kuwabara, Yusuke Isshiki, 2018

机译：多种囊性肺病灶和自身免疫性血小板减少血小阴盆治疗肺惰性B细胞淋巴瘤的肺惰性B细胞淋巴瘤
5. Bendamustine (Ribomustin®/Treanda®/ Levact®) for indolent non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukaemia (CLL) and multiple myeloma [O] . Geiger-Gritsch S. 2010

机译：苯达莫司汀（Ribomustin®/Treanda®/Levact®）用于惰性非霍奇金淋巴瘤（NHL），慢性淋巴细胞性白血病（CLL）和多发性骨髓瘤

Wrap-up Bendamustin 2015 Levact (R) proved itself as a Chemotherapy Partner in CLL and other indolent Lymphomas

著录项

相似文献

相关主题

期刊订阅